EBIM launched the Educational Platform

We are pleased to inform you that the European Board of Internal Medicine, EBIM a joint collaboration between EFIM and the UEMS Section of Internal Medicine launched the Educational Platform online.
Access here the EBIM website: https://www.ebim-online.org/ .
EBIM is committed to advancing postgraduate education in internal medicine in Europe through guidance on the standardisation of training and practice of internal medicine within Europe for the benefit of patient care. 

Tocilizumab in COVID-19 - Which Clinical Benefits?

Tocilizumab is a recombinant humanized monoclonal IL-6 receptor antibody indicated for the treatment of severe rheumatoid arthritis and other inflammatory disorders.Following clinical observation from China, a series of Italian studies have been carried out to evaluate the off-label use of tocilizumab in COVID-19 patients.
The European Journal of Internal Medicine (EJIM) has recently accepted for publication three articles on the off-label use of tocilizumab in patients with severe COVID-19.

FDIME Research Grant 2020

FDIME Announces Research Grants in 2020

The Foundation for the Development of Internal Medicine in Europe (FDIME) is offering Research Grants to Young Internists (up to age 38 yrs) to study in:
Research projects including all fields of General Internal Medicine, particularly polymorbidity and other common Internal Medicine conditions.

For details check the FDIME Research Grants webpage at www.fdime.org
OR

Download the Internal Medicine Grant Announcement and Application Form

For further information:

Fellowship

EFIM is delighted to relaunch the Fellowship programme which is designed for all members of EFIM national societies who want to be part of a global community that share the same vision. EFIM Fellowship is a professional credential that recognises and rewards physicians for  their outstanding... more

Field of Interest:
Type: Page

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness